… -Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA-3 trial
用户RV7E0FIEbNwk
1小时前
21
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-03-06 10:18:14 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
M Gooderham, S Molin, R Bissonnette…
British Journal of …, 2024
academic.oup.com
… adults with moderate to severe CHE in the randomized, double-blind, vehicle-controlled
DELTA-2 trial (2… applications of delgocitinib cream in patients with moderate to severe CHE. …
